Levels and distribution of central nervous system amines in normal and morphine-dependent monkeys by Segal, M. et al.
Neuropharmacology, 1972, 11,21 l-222 Pergamon Press. Printed in Gt. Britain. 
LEVELS AND DISTRIBUTION OF CENTRAL NERVOUS 
SYSTEM AMINES IN NORMAL AND MORPHINE- 
DEPENDENT MONKEYS* 
M. SE&&t G. A. DENEAU and M. H. SEEVERS 
Department of Pharmacology, University of Michigan, Ann Arbor 
(Accepted 17 June 1971) 
Summary-The distribution of norepinephrine, dopamine and 5-hydroxytryptamine in 
various areas of the CNS of the normal monkey has been presented. 
The central levels and distribution of norepinephrine, dopamine and 5-hydroxytryptamine 
were determined after single doses of morphine, during maintenance of physical dependence 
and following withdrawal from chronic administration of morphine. Small and non-stressful 
doses of morphine were employed to induce experimental physical dependence. 
Alpha-methyl-DOPA did not qualitatively or quantitatively alter the abstinence 
syndrome. 
Pretreatment with iproniazid did not prevent depression produced by single doses of 
morphine in the non-tolerant monkey. 
The data observed in this study offer no support for the view that gross behavioral 
changes in the monkey produced by morphine or by its withdrawal after the development 
of physical dependence are induced by or may be correlated with changes in amine levels 
in the CNS. 
CURRENT hypotheses which attempt to relate variations in behavioral and somatic 
responses to changes in catecholamine content of the CNS (e.g. HESS, CONNAMACHER, 
OZAKI and UNDENFRIEND, 1961) have inspired several investigators to search for such 
correlations during a cycle of chronic morphine administration and withdrawal (GUNNE, 
1959, 1961; MAYNERT and KLINGMAN, 1962; KLINGMAN and MAYNERT, 1962; SHEN, 
Fu-HSIUNG and WAY, 1970; EIDELBERG and SCHWARTZ, 1970; RETHY, SMITH and 
VILLARREAL, 197 1; SMITH, VILLARREAL, BEDNARCZYK and SHELDON, 1970). Theoretic- 
ally, this should be a good system to test this hypothesis since the range of somatic activity 
between the narcosis induced by a large single dose of morphine in the intact animal and 
the generalized hyperirritability of abstinence following chronic administration is about 
as great as possible short of the extremes of anesthesia and convulsions. 
Previous investigations dealing with the rat, cat, rabbit and dog have several defects; 
morphine dosage was so large that the direct stimulant effect of the drug was necessarily 
an uncontrolled factor in these experiments; morphine administration was not sufficiently 
frequent to induce a stable dependent state and catecholamine determinations in rats 
were made on aliquots of the whole brains of several animals. 
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National Academy of Sciences-National Research Council, from funds contributed by a group of 
interested pharmaceutical manufacturers. 
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In the present study, techniques designed to obviate these objections have been applied 
to the rhesus monkey (Mucaca mulatta), a species which is quite similar to man in its 
response to single and repeated administration of morphine. Norepinephrine, dopamine 
and 5hydroxytryptamine levels of selected parts of the CNS were determined after single 
doses of morphine, during maintenance of physical dependence and following withdrawal 
from chronic administration of morphine. 
METHODS 
All experiments were performed in the rhesus monkey (Mucaca muluttu). Signs of 
depression following single subcutaneous injections of morphine and of excitation on 
withdrawal of morphine from dependent animals were graded and evaluated as previously 
described (SEEVERS, 1954; DENEAU, 1958). The animals were killed at the time of maximal 
drug effect. 
Treatments. The experiments were divided into 4 groups on the basis of overt signs 
of behavior as related to the animals’ levels of CNS excitability (Table 1). Group 1 con- 
sisted of 3 subgroups of 3 animals each whose behavior was essentially normal. These 
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*Three animals in each subgroup. 
are represented in the tables as behavioral controls. The 3 subgroups were: (a) normals 
(no drug treatment), (b) animals killed 45 min following a single subcutaneous injection 
of 2 mg/kg nalorphine hydrochloride. This dose did not alter behavior in the monkey 
and served as a control for its use in precipitating withdrawal in dependent animals, 
(c) monkeys made physically dependent and tolerant to morphine sulfate on a chronic 
dosing schedule of 3 mg/kg every 6 hr and killed 90 min following the last injection of 
morphine (supported physically dependent animals). Group 2 consisted of 2 subgroups 
of 3 animals each in a state of behavioral depression. These were: (a) and (b) non-tolerant 
animals killed 90 min following single subcutaneous injections of 3 and 30 mg/kg morphine. 
Group 3 consisted of 3 subgroups of 3 animals each in a state of behavioral excitation. 
The 3 subgroups were (a) and (b) animals killed at 24 and 48 hr of abrupt withdrawal 
from morphine and (c) physically dependent animals killed at 45 min of withdrawal pre- 
cipitated by the subcutaneous administration of 2 mg/kg nalorphine. Group 4 consisted 
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of 3 non-de~ndent animals in a state of mild excitation produced by the subcu~neous 
administration of 4 mg/kg thebaine hydrochIoride. The animals were kiIIed 30 min 
following the administration of thebaine. This agent does not possess the depressant 
properties of morphine and does not induce physical dependence on chronic administration. 
Doses of all agents are expressed as their respective salts. 
Preparation of animals. Just prior to death, 1 mg/kg of heparin sodium was injected 
i.v. to facilitate perfusion of the brain. The animal was then killed by the intracardiac 
injection of 1 g pentothal sodium. In the light of evidence that there can be considerable 
diurnal variation in brain amine levels, all animals were killed between 07:OO and 07:30 
on the morning of each experiment. The brain was perfused with 200 ml of physiological 
saline at 200 mm Hg pressure in order to remove circulating amines and prevent their 
interference with the tissue assays. The calvarium was removed quickly and the brain 
along with a small section of cervical spinal cord was removed. The following parts were 
immediately dissected in a cold room at 4°C: cerebellum, dorsal thalamus, hypothalamus, 
caudate nucleus, part of the cervical spinal cord, medulla, pons, mid-brain (remaining 
part of the brain stem) and cerebra1 cortex. The time from death to the end of dissection 
was kept constant for all animals (50-70 min). Stabilizing the time-period was of the utmost 
importance at this point since loss of tissue amines occurs with the passage of time prior 
to extraction into an acid medium (EADE, 1961). 
Tissue assay. An extract of each sample was prepared according to the method of 
MOORE and BRODY (1961) except that the final volume was 10 ml. Each extract was 
divided into two equal parts. One part was used for the determination of 5-hydroxy- 
tryptamine according to the method of BOGDANSKI, PLETSCHER, BRODIE and UDENF~END 
(1957); the second part was applied to columns of alumina (Fisher, acid-washed~, eluted 
with acid and used for the determination of norepinephrine and dopamine. Nor- 
epinephrine was determined by the method of BERTLER, CARLSSON and ROSENGREN (1957) 
as modified by MOORE and BRADY (1961). Dopamine was determined by a modification 
of the method of CARLSSON and WALDECK (1958). Instead of irradiating the samples by 
means of a mercury lamp to enhance the development of fluorescence, the samples were 
allowed to stand for 1 hr at room temperature in a fluorescent-lit room before reading the 
fluorescence in an Aminco-Bowman spectrophotofluorometer. 
Percentage recoveries (&SD.) of norepinephrine, dopamine and 5hydroxytryptamine 
simultaneousty added to brain were: norepinephrine, 84 16 ; dopamine, 67 13 ; and 
5_hydroxytryptamine, 106-&3. The amines were always analyzed in a single sample of 
brain. There was no cross interference by any of the amines in any of the assay procedures. 
~tat~sticul ana~ses. The data were analyzed statistically on an IBM 709 computer 
using the Analysis of Variance (FISHER, 1958) and the Duncan’s MultipIe Range Test 
(DUNCAN, 1955). 
In vivo studies with enzyme inhibitors, reserpine and morphine 
1. Alpha-methyl-DOPA. Alpha-methyl-DOPA was injected i.p. in a dose range of 
50-600 mg/kg into 16 normal monkeys, i.v. in a dose range of 5-400 mg/kg to 6 normal 
monkeys and orally to 12 normal monkeys in a dose range of 100-600 mg/kg. The animals 
were observed and graded for 12-17 hr. Alpha-methyl-DOPA (400 mg/kg) was also 
injected i.v. into 4 physically dependent monkeys at 6,8, 10 and 12 hr of abrupt withdrawal 
from morphine which were then observed for a further 6 hr. 
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2. Iproniazid, reserpine, morphine. Three normal monkeys were pretreated for 3 con- 
secutive days with a total of 100 mg/kg iproniazid (isonicotinic acid-N-isopropyl hydrazide 
phosphate) subcutaneously. Twenty-four hours after the last injection of iproniazid, 
1 animal was administered O-5 mgfkg reserpine i.v,, the second, 3 mgikg morphine sub- 
cutaneously and the third served as a control. As controls for the pretreated animals, 
2 untreated animals were administered 0.5 mg/kg reserpine and 3 mg/kg morphine 
respectively. All animals were graded for 8 hr following drug treatment. 
RESULTS 
Tables 2-4 summarize the levels and distribution of norepinephrine, dopamine and 
5-hydroxytryptamine in the various areas of the monkey’s CNS under 3 states of CNS 
excitability: overtly normal (behavioral controls), depression (morphine) and excitation 
(withdrawal). This type of presentation was selected since the numerous individual data 
were statistically insignificant. To indicate the degree of change we have selected the 
hypothalamus (Table 5). The hypothalamus was selected for illustrative purposes because 
of its likely involvement in the morphine abstinence syndrome during which a marked 
imbalance in autonomic function occurs and also in view of the fact that the relative level 
of amines found in this area reduce the methodological error. 
1. Normal amine distribution, Norepinephrine was found in highest concentration in 
the hypothalamus (Table 2). The norepinephrine content of the hypothalamus was found 
to be approximately 3 times that of the dog and cat (VOGT, 1954). The norepinephrine 
levels in the other areas were similar to those reported for the dog and cat (VOGT, 1954). 
In the hypothalamus, they ranged from 2 to 4 pg/g, in the thalamus, medulla and mid- 
brain from O-2 to 0.5 pg/g, in the pons and caudate nucleus from 0.1 to 0.2 pg/g and in 
the cerebellum, cerebral cortex and cervical spinal cord, less than O-1 t.tg/g. Dopamine 
was most concentrated in the caudate nucleus (Table 3); small but variable amounts 
were present in all other areas. 5-Hydroxytryptamine, like norepinephrine, was most 
concentrated in the hypothalamus and mid-brain (Table 4). Other areas with a high 
content of 5-hydroxytryptamine were the thalamus, medulla, pons and caudate nucleus. 
Low levels were found in the cerebellum, cerebral cortex and cervical spinal cord. 
2. Physicai dependence cycle. Tables 2-4 show the distribution of the amines in the 
various areas of the monkey’s CNS under different behavioral conditions. These tables 
demonstrate that only one statistically significant alteration occurred in the levels of 
distribution of these amines between the behavioral extremes of morphine depression and 
withdrawal excitation. Injections of 3-30 mg/kg morphine significantly (P < 0.01) increased 
the cervical spinal cord level of norepinephrine (Table 2). Other trends towards altered 
amine levels with the various treatments were not signi~~nt. 
During the mild behavioral excitation induced by the injection of 4 mg/kg thebaine, 
no significant alterations in CNS amine levels were observed (Table 5). 
Marked variations from animal to animal obviated any correlations between dopamine 
and 5-hydroxytryptamine levels and treatments (Tables 3 and 4). 
In vivo studies with enzyme ~~ibi~ors~ reserpine and morphj~e 
Even though no statistically significant alterations in CNS amine levels were produced 
with the various treatments further in vivo studies were performed in order to determine 
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dependence to morphine. Agents known to affect the level of CNS excitability and to 
alter CNS amine levels were used. 
1. Alpha-methyl-PAPA. Alplla-methyl-DOPA did not produce significant signs of 
sedation in normal monkeys and did not qualitatively or quantitatively alter the abstinence 
syndrome. 
2. Iproniazid, reserpine, morphine. Pretreatment of the monkey for 3 days with a 
total of 100 mg/kg of the monoamine oxidase inhibitor, iproniazid, did not consistently 
prevent the depression produced by an i.v. injection of O-5 mg/kg reserpine and did not 
qualitatively or quantitativeIy alter the depression produced by a subcutaneous dose of 
3 mg/kg morphine in the nontolerant monkey. 
DISCUSSION 
The important question to be answered in the present study was: could the extremes 
of ~haviora~ signs as observed during acute administration of morphine (depression) and 
withdrawal of morphine from dependent animals (excitation} be correlated with an altered 
level of distribution of CNS amines? 
VOGT (1954) showed that the hypothalamus of dogs and cats contained the highest 
concentration of norepinephrine and that high doses of morphine (30-60 mg/kg) reduced 
the levels in cats but not in dogs. GUNNE (1959) reported that 30 mg/kg morphine decreased 
levels of rat brain norepinephrine, but doses of 60-90 mg/kg morphine increased these 
levels. From these studies it would appear that doses of morphine which produce overt 
behavioral depression depress brain norepinephrine levels while doses which produce 
overt stimulation increase these levels. Although they did not report the behavioral effects 
of the doses they employed, MAYNERT and KLMGMAN (1962) reported depressed levels 
of brain catecholamines with all doses (60-150 mg/kg to rats and up to 200 mgfkg to 
dogs). The higher doses which they used in rats and dogs are known to produce mixed 
signs of overt depression and stimulation. 
Contrary to the findings of GuNNE (1959,1961), SLOAN, BROOKS, EISENMAN and MARTIN 
(1963) reported that brain catecholamine levels showed a statistically significant increase 
over saline controls in their experimental design where rats received twice daily sub- 
cutaneous injections of mo~hine sulfate starting at a dose of 5 mg~kg~day with increases 
up to 400 mgjkglday over a 40-day period. The present data are at variance with these 
findings since small, and, for the monkey, moderately depressant doses of morphine 
(3 and 30 mg/kg) did not alter CNS catecholamine levels significantly except in the cervical 
spinal cord in which both doses produced an increase. There is no correlation between 
the effect of morphine on brain catecholamine levels and on CNS excitability among the 
various species studied thus far. 
GZ~NNE (1959) reported that rat brain norepinephrine levels decreased during with- 
drawal from morphine following a 3-week chronic dosing schedule of 20 mg/kg increasing 
to 200 mg/kg per dose, injected i.p., twice daily. MAYNERT and KLINGMAN (1962) con- 
firmed this finding during withdrawal in dogs and rabbits but observed no changes during 
withdrawal of morphine from rats. In the present study, the catecholamine levels did not 
change significantly during withdrawal from morphine. The inconsistency of the data in 
these several studies fail to support the view that changes in brain norepinephrine levels 
are causally related to CNS hyperexcitability associated with the morphine abstinence 
syndrome. 
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Differences observed between the results of this study and those of other investigators 
might be due to: (1) the species chosen as experimental animal; (2) the dose and schedule 
employed to induce physical dependence to morphine and (3) the analysis of individual 
CNS areas as opposed to total or pooled brain analyses. These differences can be further 
qualified as follows: (1) Many factors influence drug metabolism (CONNEY and BURNS, 1962) 
COSTA, GESSA, HIRSCH, KUNTZMAN and BRODIE (1962) reported that iproniazid pretreat- 
ment prevented reserpine depression in mice. As presently reported, this phenomenon did 
not occur consistently in the monkey. Variation between species as well as within a species 
must be considered when interpreting data. (2) When doses of morphine in the range of 
30-200 mg/kg are injected once or twice daily to produce physical dependence, the animals 
are in a sequence of stressing conditions due to alternating daily periods of morphine 
excitation and withdrawal. Doses in the higher range produce primary excitation and 
severe secondary depression. It is impossible under these conditions to establish a relatively 
steady state which corresponds to that which exists in man or the monkey when small 
doses are administered at frequent intervals. In the monkey, the maximal stabilizing period 
between injections of small doses of morphine (3 mg/kg) has been shown to be 6 hr 
(DENEAU, 1958). The animals show only mild signs of depression after injection and do 
not show withdrawal hyperirritability between injections. We believe the changes in 
catecholamine levels observed in small animals with large infrequent dosage of morphine 
to be a reflection of experimental design rather than a true manifestation of behavioral 
effects related to physical dependence. (3) A detailed study of the distribution of CNS 
amines under various conditions (e.g. physical dependence cycle) offers more opportunity 
to detect meaningful changes than analyses of total or pooled brain samples. 
It should be stressed that negative results obtained with methods designed to measure 
only tissue content, like those described here, do not exclude amines from final con- 
sideration in attempts to correlate biochemical change with behavior since such methods 
offer no information concerning rates of formation, release or degradation. 
Recently, SHEN et al. (1970) and SMITH et aZ. (1970) reported increased turnover rates 
of 5-hydroxytryptamine and catecholamines in morphine-tolerant and -dependent mice 
and rats. Although the conclusions reached relate to an association between amine turn- 
over and the morphine physical dependence cycle, no causal relationships were established. 
Further experimentation by MARSHALL and GRA~ME-SMITH (1970) failed to confirm the 
SEEN et al. (1970~ increase in 5-hydroxytryptamine turnover and although MARUYAMA, 
HAYASHI and TAKEMORI (1970) found no causal relation between brain 5-hydroxy- 
tryptamine metabolism and physical dependence, they concluded that some relation 
between tolerance and %hydroxytryptamine turnover may exist. CHENEY, GOLDSTEIN, 
ALGERI and COSTA (1971) and ALGERI and COSTA (1971), however, have recently furnished 
evidence that serotonin turnover in the brain is not related to morphine-tolerant and 
-dependence. There is as yet no final agreement that altered amine kinetics are a causal 
factor in morphine physical dependence. 
Altered dopamine levels observed during the various stages of CNS hyperirritability 
encountered in a cycle of physical dependence to morphine might suggest a role in this 
syndrome apart from its being a precursor of norepinephrine. In viva studies with a-methyl 
DOPA showed that this agent, which prevents the decarboxylation of DOPA and depresses 
the central dopamine levels in various species ranging from mouse to man (HESS, 1954; 
OATES, GILLESPIE, UDENFRIEND and SJOERDSMA, 1960; PORTER, T~TAR~ and LEIBY, 
1961) decreased the intensity of the morphine abstinence syndrome in mice (HUIDOBRO, 
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CONTRERAS and CROXATTO, 1963) and altered at least some of the behavioral effects of 
administered morphine (EIDELBERG and SCHWARTZ, 1970), did not qualitatively or 
quantitatively alter the abstinence syndrome in the monkey. Assuming that a-methyl 
DOPA affects CNS amine levels in monkeys, as in other species, dopamine is probably 
not causally related to the development of physical dependence to morphine. 
Iproniazid is known to alter CNS amine levels in mice, rats, rabbits, cats, dogs and 
man (SPECTOR, PROCKOP, SHORE and BRODII?, 1958; LEROY and DE~CHAEPDRYVER, 1961; 
GAMROT, ROSENGREN and GOTTFRIES, 1962) to affect the level of CNS excitability in these 
same species (SPECTOR et al., 1958 ; PARE, 1959) and to lessen or prevent reserpine depression 
and locomotor effects in mice (SMITH and DEWS, 1962; COSTA et af., 1962; MARSHALL 
and GRAHAME-SMITH, 1970). Pretreatment of nontoIerant monkeys with iproniazid did 
not prevent depression produced by the acute injection of morphine. Assuming that 
iproniazid affects monoamines and monoamine oxidase in monkeys as in other species, 
it appears that the depressant action of morphine is not dependent on the levets of these 
amines. 
We confirm the results of others (BRODIE, SHORE and PLETSCHER, 1956; MA~ERT, 
KLINGMAN and HIDEKO, 1962; SLOAN et al., 1963) that 5-hydroxytryptamine is not altered 
during the various stages of CNS excitability encountered during a cycle of physical 
dependence to morphine. 
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